First drug to treat irritability associated with autism.

Suppr

超能文献

出版信息

FDA Consum. 2007 Jan-Feb;41(1):4.

PMID:17342827

Abstract

摘要

相似文献

First drug to treat irritability associated with autism.

FDA Consum. 2007 Jan-Feb;41(1):4.

Pharmacotherapy of irritability in pervasive developmental disorders.

Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):739-52, vii-viii. doi: 10.1016/j.chc.2008.06.002.

Risperidone: a potential treatment for autism.

Curr Opin Investig Drugs. 2002 Aug;3(8):1212-6.

[Treatment of behavioral disorders by risperidone in children with autism].

Zhongguo Dang Dai Er Ke Za Zhi. 2011 Mar;13(3):216-8.

Risperidone use in the treatment of behavioral symptoms in children with autism.

Pediatr Nurs. 2006 Nov-Dec;32(6):545-9.

Examining risperidone use in those diagnosed with autism 1 year after FDA approval.

J Clin Psychiatry. 2010 May;71(5):651-2. doi: 10.4088/JCP.09l05665yel.

Risperidone approved for the treatment of serious behavioral problems in children with autism.

J Child Adolesc Psychiatr Nurs. 2007 Aug;20(3):188-90. doi: 10.1111/j.1744-6171.2007.00112.x.

Antipsychotic drugs in children with autism.

BMJ. 2007 May 26;334(7603):1069-70. doi: 10.1136/bmj.39216.583333.80.

Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial.

J Autism Dev Disord. 2007 Feb;37(2):367-73. doi: 10.1007/s10803-006-0234-7.

[Risperidone use in child and adolescent psychiatric patients].

Therapie. 2008 Sep-Oct;63(5):359-75. doi: 10.2515/therapie:2008059. Epub 2009 Jan 21.

引用本文的文献

Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models.

Front Cell Neurosci. 2018 Nov 20;12:422. doi: 10.3389/fncel.2018.00422. eCollection 2018.

Obesity Prevention for Children with Developmental Disabilities.

Curr Obes Rep. 2014 Jun;3(2):156-70. doi: 10.1007/s13679-014-0098-7.

Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents.

Ther Adv Psychopharmacol. 2013 Oct;3(5):278-93. doi: 10.1177/2045125313487548.

Correlates of weight gain during long-term risperidone treatment in children and adolescents.

Child Adolesc Psychiatry Ment Health. 2012 May 29;6(1):21. doi: 10.1186/1753-2000-6-21.

Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.

Pharmacogenet Genomics. 2009 May;19(5):373-82. doi: 10.1097/FPC.0b013e328329a60f.

The neuropathology of autism.

Brain Pathol. 2007 Oct;17(4):422-33. doi: 10.1111/j.1750-3639.2007.00100.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

First drug to treat irritability associated with autism.

FDA Consum. 2007 Jan-Feb;41(1):4.

Pharmacotherapy of irritability in pervasive developmental disorders.

Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):739-52, vii-viii. doi: 10.1016/j.chc.2008.06.002.

Risperidone: a potential treatment for autism.

Curr Opin Investig Drugs. 2002 Aug;3(8):1212-6.

[Treatment of behavioral disorders by risperidone in children with autism].

Zhongguo Dang Dai Er Ke Za Zhi. 2011 Mar;13(3):216-8.

Risperidone use in the treatment of behavioral symptoms in children with autism.

Pediatr Nurs. 2006 Nov-Dec;32(6):545-9.

Examining risperidone use in those diagnosed with autism 1 year after FDA approval.

J Clin Psychiatry. 2010 May;71(5):651-2. doi: 10.4088/JCP.09l05665yel.

Risperidone approved for the treatment of serious behavioral problems in children with autism.

J Child Adolesc Psychiatr Nurs. 2007 Aug;20(3):188-90. doi: 10.1111/j.1744-6171.2007.00112.x.

Antipsychotic drugs in children with autism.

BMJ. 2007 May 26;334(7603):1069-70. doi: 10.1136/bmj.39216.583333.80.

Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial.

J Autism Dev Disord. 2007 Feb;37(2):367-73. doi: 10.1007/s10803-006-0234-7.

[Risperidone use in child and adolescent psychiatric patients].

Therapie. 2008 Sep-Oct;63(5):359-75. doi: 10.2515/therapie:2008059. Epub 2009 Jan 21.

引用本文的文献

Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models.

Front Cell Neurosci. 2018 Nov 20;12:422. doi: 10.3389/fncel.2018.00422. eCollection 2018.

Obesity Prevention for Children with Developmental Disabilities.

Curr Obes Rep. 2014 Jun;3(2):156-70. doi: 10.1007/s13679-014-0098-7.

Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents.

Ther Adv Psychopharmacol. 2013 Oct;3(5):278-93. doi: 10.1177/2045125313487548.

Correlates of weight gain during long-term risperidone treatment in children and adolescents.

Child Adolesc Psychiatry Ment Health. 2012 May 29;6(1):21. doi: 10.1186/1753-2000-6-21.

Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.

Pharmacogenet Genomics. 2009 May;19(5):373-82. doi: 10.1097/FPC.0b013e328329a60f.

The neuropathology of autism.

Brain Pathol. 2007 Oct;17(4):422-33. doi: 10.1111/j.1750-3639.2007.00100.x.